Novo Nordisk Faces Class Claims Over GLP-1 Patent Tactics
By Elliot Weld · January 26, 2026, 4:45 PM EST
A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong its monopoly against generic competition for...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login